34 related articles for article (PubMed ID: 22902286)
1. Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats.
Zhu M; Chen Y; Cheng L; Li X; Shen Y; Guo G; Xu X; Li H; Yang H; Liu C; He K
Cardiovasc Drugs Ther; 2024 Apr; 38(2):237-252. PubMed ID: 36350487
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms.
Berlanga-Acosta J; Cibrian D; Valiente-Mustelier J; Suárez-Alba J; García-Ojalvo A; Falcón-Cama V; Jiang B; Wang L; Guillén-Nieto G
Front Pharmacol; 2024; 15():1402138. PubMed ID: 38873418
[No Abstract] [Full Text] [Related]
3. Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway.
Shabaan DA; Mostafa N; El-Desoky MM; Arafat EA
Tissue Barriers; 2023 Jan; 11(1):2019504. PubMed ID: 34939895
[TBL] [Abstract][Full Text] [Related]
4. Weighted gene co-expression network-based approach to identify key genes associated with anthracycline-induced cardiotoxicity and construction of miRNA-transcription factor-gene regulatory network.
Wan G; Chen P; Sun X; Cai X; Yu X; Wang X; Cao F
Mol Med; 2021 Nov; 27(1):142. PubMed ID: 34732131
[TBL] [Abstract][Full Text] [Related]
5. The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study.
Rahmanifard M; Vessal M; Noorafshan A; Karbalay-Doust S; Naseh M
Cardiovasc Toxicol; 2021 Nov; 21(11):936-946. PubMed ID: 34339022
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide ameliorates doxorubicin‑induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway.
Nie L; Liu M; Chen J; Wu Q; Li Y; Yi J; Zheng X; Zhang J; Chu C; Yang J
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33649809
[TBL] [Abstract][Full Text] [Related]
7. Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy.
Silva Dos Santos D; Brasil GV; Ramos IPR; Mesquita FCP; Kasai-Brunswick TH; Christie MLA; Cahli GM; Barbosa RAQ; da Cunha ST; Pereira JX; Medei E; Campos de Carvalho AC; Carvalho AB; Goldenberg RCDS
Stem Cell Res Ther; 2018 Feb; 9(1):30. PubMed ID: 29402309
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish Larvae Model of Dilated Cardiomyopathy Induced by Terfenadine.
Gu G; Na Y; Chung H; Seok SH; Lee HY
Korean Circ J; 2017 Nov; 47(6):960-969. PubMed ID: 29035434
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats.
Mao C; Hou X; Wang B; Chi J; Jiang Y; Zhang C; Li Z
Stem Cell Res Ther; 2017 Jan; 8(1):18. PubMed ID: 28129792
[TBL] [Abstract][Full Text] [Related]
10. Developing a rat model of dilated cardiomyopathy with improved survival.
Shen LJ; Lu S; Zhou YH; Li L; Xing QM; Xu YL
J Zhejiang Univ Sci B; 2016 Dec.; 17(12):975-983. PubMed ID: 27921402
[TBL] [Abstract][Full Text] [Related]
11. An Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy.
Talavera J; Giraldo A; Fernández-Del-Palacio MJ; García-Nicolás O; Seva J; Brooks G; Moraleda JM
Biomed Res Int; 2015; 2015():465342. PubMed ID: 26788502
[TBL] [Abstract][Full Text] [Related]
12. Effects of PPARα/PGC-1α on the myocardial energy metabolism during heart failure in the doxorubicin induced dilated cardiomyopathy in mice.
Yang Y; Zhang H; Li X; Yang T; Jiang Q
Int J Clin Exp Med; 2014; 7(9):2435-42. PubMed ID: 25356095
[TBL] [Abstract][Full Text] [Related]
13. A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin.
Heger Z; Cernei N; Kudr J; Gumulec J; Blazkova I; Zitka O; Eckschlager T; Stiborova M; Adam V; Kizek R
Int J Mol Sci; 2013 Oct; 14(11):21629-46. PubMed ID: 24185911
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin induced dilated cardiomyopathy in a rabbit model: an update.
Gava FN; Zacché E; Ortiz EM; Champion T; Bandarra MB; Vasconcelos RO; Barbosa JC; Camacho AA
Res Vet Sci; 2013 Feb; 94(1):115-21. PubMed ID: 22902286
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular function in patients with toxic cardiomyopathy and with idiopathic dilated cardiomyopathy treated with Doxorubicin.
Katamadze NA; Lartsuliani KP; Kiknadze MP
Georgian Med News; 2009 Jan; (166):43-8. PubMed ID: 19202217
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy.
Ishida M; Tomita S; Nakatani T; Fukuhara S; Hamamoto M; Nagaya N; Ohtsu Y; Suga M; Yutani C; Yagihara T; Yamada K; Kitamura S
J Heart Lung Transplant; 2004 Apr; 23(4):436-45. PubMed ID: 15063403
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity.
Khan M; Shobha JC; Mohan IK; Naidu MU; Sundaram C; Singh S; Kuppusamy P; Kutala VK
Phytother Res; 2005 Dec; 19(12):1030-7. PubMed ID: 16372368
[TBL] [Abstract][Full Text] [Related]
18. [Cardiological monitoring of patients treated with doxorubicin].
Mahaux V; Demoulin JC; Closon MT; Jardon-Jeghers C; Vivario M; Kulbertus H
Rev Med Liege; 1988 Jun; 43(12):449-55. PubMed ID: 3041526
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
